Print this article
P. 39-40 /

Dr. Thomas Fruh – CEO – Bachem


e-version image

Click HERE to download the PDF version



Bachem is an independent, technology-based, public company, specialized in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as innovative biochemicals for research purposes. Bachem’s founding vision is to be the undisputed leader in peptides. In continuing to fulfil this vision, the company has taken the decision to re-focus on its core business and to grow in peptides